U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06797219) titled 'Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4' on Aug. 06, 2024.
Brief Summary: The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers' experience with the study intervention. A complete list of objectives and aims a...